Echinocandins - First Line in Invasive Candidiasis: How Strong Is This 'Strong' Evidence?

Critical Care - United Kingdom
doi 10.1186/cc10580
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Periodontal Infection and Preterm Birth: How Strong Is the Evidence?

New South Wales Public Health Bulletin
1999English

How to Make Strong Acids Turn This Thick.

Chemical and Engineering News
Chemical Engineering
1968English

Prevention of Obesity by Dietary Resveratrol: How Strong Is the Evidence?

Expert Review of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2015English

Strong Epidemiological Evidence That Alcohol Causes Cancer, but How Might the Public Interpret This Information?

Addiction
MedicinePsychiatryMental Health
2016English

Echinocandins for Management of Invasive Candidiasis in Patients With Liver Disease and Liver Transplantation

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Azithromycin in Bronchiolitis Obliterans: Is the Evidence Strong Enough?

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2006English

How Strong Is the Effect of Learning in the Workplace?

2019English

Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: How Strong Is the Evidence?

BMJ
2005English

How Strong Is the Case for Downward Real Wage Rigidity?

SSRN Electronic Journal
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy